Stock data
Tonix Pharmaceuticals Holding Corp. (TNXP)
Tonix Pharmaceuticals Holding Corp. (TNXP) reported revenue of US$13.11M and net income of -US$124.02M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$13.11M | — | -US$125.70M | -US$124.02M | — |
| 2024 | US$10.09M | — | -US$136.70M | -US$130.04M | — |
| 2023 | US$7.77M | — | -US$118.38M | -US$116.66M | — |
| 2022 | — | — | -US$112.09M | -US$110.22M | — |
| 2021 | — | — | -US$92.31M | -US$92.29M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$13.54M | -US$40.55M | — |
| 2026-03-31 | US$6.88M | -US$40.19M | — |
| 2025-12-31 | US$5.39M | -US$46.91M | — |
| 2025-09-30 | US$3.29M | -US$32.01M | — |
| 2025-06-30 | US$2.00M | -US$28.27M | — |
| 2025-03-31 | US$2.43M | -US$16.83M | — |
| 2024-12-31 | US$2.58M | -US$22.11M | — |
| 2024-09-30 | US$2.82M | -US$14.21M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.